JAFA founder Professor Ruth Colagiuri AM said, "An average of a year is a long time for kids to have painful and damaging inflammation gnawing at their joints and eyes while awaiting diagnosis of JA. This program is exactly what is needed to reduce these disabling delays and help transform kids’ lives from chronic disease to chronic health."
Minister to launch first major program targeting early diagnosis of juvenile arthritis
March 20, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Island Pharmaceuticals secures key partnership with Texas Biomed
December 17, 2025 - - Australian Biotech -
Novartis names new Country President following leadership transition
December 16, 2025 - - Latest News -
Mayne Pharma opens expanded manufacturing facility after termination of takeover
December 16, 2025 - - Latest News -
Budget update includes impact of listings, but generally not much else
December 16, 2025 - - Latest News -
The UK reconfirms the direct impact of the transatlantic shift in medicine pricing
December 16, 2025 - - Latest News -
The industry is probably right to resist, it just needs to prepare for the response
December 16, 2025 - - Latest News -
Cynata completes patient enrolment in Phase 2 trial for aGvHD therapy
December 15, 2025 - - Australian Biotech
